CSS LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $827K | Sell |
34,351
-2,770
| -7% | -$72.5K | 0.03% | 405 |
|
|
2026
Q1 | $1.04M | Sell |
37,121
-5,050
| -12% | -$134K | 0.05% | 321 |
|
|
2025
Q4 | $1.05M | Buy |
42,171
+30,921
| +275% | +$780K | 0.05% | 307 |
|
|
2025
Q3 | $287K | Sell |
11,250
-23,530
| -68% | -$581K | 0.01% | 686 |
|
|
2025
Q2 | $843K | Sell |
34,780
-16,780
| -33% | -$391K | 0.04% | 384 |
|
|
2025
Q1 | $1.31M | Buy |
51,560
+20,701
| +67% | +$542K | 0.07% | 213 |
|
|
2024
Q4 | $819K | Sell |
30,859
-2,240
| -7% | -$60.8K | 0.04% | 403 |
|
|
2024
Q3 | $958K | Buy |
33,099
+17,100
| +107% | +$499K | 0.04% | 313 |
|
|
2024
Q2 | $448K | Sell |
15,999
-4,000
| -20% | -$110K | 0.02% | 521 |
|
|
2024
Q1 | $555K | Sell |
19,999
-9,000
| -31% | -$250K | 0.03% | 416 |
|
|
2023
Q4 | $835K | Sell |
28,999
-14,000
| -33% | -$423K | 0.05% | 290 |
|
|
2023
Q3 | $1.43M | Buy |
42,999
+10,000
| +30% | +$354K | 0.09% | 179 |
|
|
2023
Q2 | $1.21M | Buy |
32,999
+9,100
| +38% | +$354K | 0.07% | 199 |
|
|
2023
Q1 | $975K | Buy |
23,899
+8,000
| +50% | +$346K | 0.06% | 208 |
|
|
2022
Q4 | $815K | Hold |
15,899
| – | – | 0.05% | 298 |
|
|
2022
Q3 | $696K | Buy |
15,899
+5,399
| +51% | +$262K | 0.03% | 435 |
|
|
2022
Q2 | $551K | Sell |
10,500
-1,500
| -13% | -$76.4K | 0.02% | 549 |
|
|
2022
Q1 | $622K | Buy |
12,000
+2,000
| +20% | +$104K | 0.02% | 562 |
|
|
2021
Q4 | $590K | Buy |
10,000
+8,000
| +400% | +$396K | 0.02% | 601 |
|
|
2021
Q3 | $86K | Buy |
+2,000
| New | +$88.6K | ﹤0.01% | 995 |
|
|
2020
Q3 | – | Sell |
-53,668
| Closed | -$1.88M | – | 853 |
|
|
2020
Q2 | $1.67M | Buy |
+53,668
| New | +$1.82M | 0.09% | 197 |
|
|
2015
Q3 | – | Sell |
-16,321
| Closed | -$519K | – | 809 |
|
|
2015
Q2 | $519K | Hold |
16,321
| – | – | 0.02% | 431 |
|
|
2015
Q1 | $539K | Hold |
16,321
| – | – | 0.03% | 415 |
|
|
2014
Q4 | $482K | Hold |
16,321
| – | – | 0.02% | 443 |
|
|
2014
Q3 | $458K | Hold |
16,321
| – | – | 0.02% | 491 |
|
|
2014
Q2 | $460K | Hold |
16,321
| – | – | 0.02% | 484 |
|
|
2014
Q1 | $497K | Hold |
16,321
| – | – | 0.03% | 405 |
|
|
2013
Q4 | $474K | Buy |
+16,321
| New | +$475K | 0.02% | 410 |
|
Other funds holding PFE
CSS LLC's PFE Position: Q2 2026 in Review
CSS LLC reduced its Pfizer (PFE) stake by 7.5% in Q2 2026, selling an estimated $72.5K and leaving 34,351 shares worth $827K. The position accounts for 0.03% of the portfolio, ranked #405.
CSS LLC first reported a position in PFE in Q4 2013 and has held it in 28 quarters since. The position peaked at $1.67M in Q2 2020. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- CSS LLC held 34,351 shares of Pfizer worth $827K as of Q2 2026.
- CSS LLC sold 2,770 Pfizer shares in Q2 2026, an estimated $72.5K.
- Pfizer made up 0.03% of CSS LLC's portfolio in Q2 2026, its #405 holding.
- CSS LLC first reported a position in Pfizer in Q4 2013 and has held it in 28 quarters since.
- CSS LLC's Pfizer position peaked at $1.67M in Q2 2020.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.